Who is sponsoring NCT07224126?

NCT07224126 is sponsored by HabitAware Inc..

What drugs are being tested in NCT07224126?

Interventions in NCT07224126: Keen2 Predictive Awareness Bracelet.

What condition does NCT07224126 study?

NCT07224126 studies Trichotillomania.

Is NCT07224126 still recruiting?

NCT07224126 is currently recruiting now. Last updated 10 November 2025.

Last reviewed 2025-11-10 · How we verify

NCT07224126

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Technology Assisted Treatment of Trichotillomania: Open Trial

Recruiting now NA Last updated 10 November 2025

What this trial tests

NA trial testing Keen2 Predictive Awareness Bracelet in Trichotillomania in 10 participants. Currently enrolling.

Timeline

15 September 2025

Primary endpoint
9 January 2026

9 January 2026

Quick facts

Lead sponsor	HabitAware Inc.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	15 September 2025
Primary completion	9 January 2026
Estimated completion	9 January 2026
Sites	1 location across United States

Drugs / interventions tested

Keen2 Predictive Awareness Bracelet

Conditions studied

Trichotillomania — all drugs for Trichotillomania →

Sponsor

HabitAware Inc.

Who can join

18 and older, any sex, with Trichotillomania. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will use the bracelet for eight weeks. During the first four weeks, they will wear the device and log contextual information (such as emotions, location, and activity) after each detected hair-pulling episode. Based on these data, participants will then receive tailored predictive alerts designed to support use of stimulus control, competing responses, and coping strategies. The study will assess usability, adherence, and changes in self-reported hair-pulling severity and awareness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Trichotillomania

Currently open trials in the same condition.

NCT02747771 — Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder) · recruiting

Other HabitAware Inc. trials

Trials by the same sponsor.

NCT04241120 — Feasibility Study for Treating Trichotillomania With Wearable Device and App System · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07224126 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HabitAware Inc.
Last refreshed: 10 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07224126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing